NCT00802321View on ClinicalTrials.gov

Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Alcohol Related DisordersAlcoholismAlcohol Abuse
Interventions
DRUG

Dutasteride

Subjects will receive a single dose of 2, 3 or 4 mg of dutasteride based on random assignment.

Trial Locations (1)

06030

Unversity of Connecticut Health Center, Farmington

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

UConn Health

OTHER

NCT00802321 - Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects | Biotech Hunter | Biotech Hunter